Observational studyBMC pulmonary medicine2024

Baseline genetic abnormalities and effectiveness of osimertinib treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC based on performance status.

Yoshihiko Taniguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.